Germany
Japan
United Kingdom
China
Antibodies
View as table Download
Rat Anti-Human CD197 (CCR7) Purified (100 ug)
| Reactivities | Human |
| Conjugation | Unconjugated |
GDF15 Rat Monoclonal (6D12.H10.E4) Antibody
| Applications | IHC |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
Rat Anti-Human/Mouse Integrin beta 7 Purified (100 ug)
| Applications | FC |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
Rat Anti-Human/Mouse CD45R (B220) Purified (100 ug)
| Applications | FC |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
USD 160.00
In Stock
Rat Anti-Human/Mouse CD49f (Integrin alpha 6) Purified (50 ug)
| Applications | FC |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
Rat Anti-Human CD209 (DC-SIGN) Purified (25 ug)
| Applications | FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Rat Anti-Human/Mouse CD44 Purified (100 ug)
| Applications | FC |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
Rat Anti-Human CMKLR1 Purified (25 ug)
| Reactivities | Human |
| Conjugation | Unconjugated |
Rat Anti-Human CD115 (c-fms) Purified (25 ug)
| Applications | FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Rat Anti-Human VEGF Receptor 1 (Flt1) Purified (25 ug)
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Rat Anti-Human CD104 (Integrin beta 4) Purified (100 ug)
| Applications | FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Rat Anti-Human CD289 (TLR9) Purified (25 ug)
| Applications | FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Mouse monoclonal GRP94 Antibody
| Applications | WB |
| Reactivities | Bovine, Canine, Chicken, Guinea Pig, Hamster, Human, Monkey, Mouse, Rabbit, Rat, Sheep, Xenopus, Pig, Horse |
| Conjugation | Unconjugated |
Rat Monoclonal anti-IRF4 Antibody
| Applications | WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
Rat Monoclonal anti-mouse BiP Antibody
| Applications | WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
Rat Monoclonal anti-mMCP-8 Antibody
| Applications | WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Rat Monoclonal anti-BID Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Rat Monoclonal TLR4 Antibody (MTS510)
| Applications | FC |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
TA336405 is a possible alternative to AM26522FC-N.
Rat monoclonal Anti-Integrin aVb6 Clone AvB6 53a.2
| Reactivities | Human |
| Conjugation | Unconjugated |
Rat monoclonal Anti-Integrin aVβ6 Clone Avβ6 62ow.17
| Reactivities | Human |
| Conjugation | Unconjugated |
Mouse anti IL-4 Monoclonal Antibody
| Reactivities | Human |
| Conjugation | Unconjugated |
Mouse anti IL-6 Monoclonal Antibody
| Reactivities | Human |
| Conjugation | Unconjugated |
Mouse anti IL-10 Monoclonal Antibody
| Reactivities | Human |
| Conjugation | Unconjugated |
Mouse anti TNF alpha Monoclonal Antibody
| Reactivities | Human |
| Conjugation | Unconjugated |
Carrier-free (BSA/glycerol-free) ALK rat monoclonal antibody, clone OTI5F4 (formerly 5F4)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Carrier-free (BSA/glycerol-free) ALK rat monoclonal antibody, clone OTI3H7 (formerly 3H7)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Carrier-free (BSA/glycerol-free) ALK rat monoclonal antibody, clone OTI1C2 (formerly 1C2)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Carrier-free (BSA/glycerol-free) ALK rat monoclonal antibody, clone OTI13A1 (formerly 13A1)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Carrier-free (BSA/glycerol-free) ALK rat monoclonal antibody, clone OTI1C6 (formerly 1C6)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Active filters
Antibody Hosts
- Rat
Conjugates
- Unconjugated
Families
- Druggable Genome
Filter by
Category
Target Symbol
- ALK (30)
- MKI67 (27)
- EBI3 (6)
- IL10 (2)
- ITGAV (2)
- PECAM1 (2)
- AKT2 (1)
- BCL11B (1)
- BID (1)
- CAMK2B (1)
- CCR7 (1)
- CD209 (1)
- CD44 (1)
- CD46 (1)
- CMKLR1 (1)
- CSF1R (1)
- FLT1 (1)
- GDF15 (1)
- HSP90B1 (1)
- HSPA5 (1)
- IL4 (1)
- IL6 (1)
- IRF4 (1)
- ITGA6 (1)
- ITGB4 (1)
- ITGB7 (1)
- LIF (1)
- PTPRC (1)
- TLR2 (1)
- TLR4 (1)
- TLR9 (1)
- TNF (1)
- TUBA1A (1)
Reactivities
Clonalities
Knockout (KO) Validation
Pathways
- Cytokine-cytokine receptor interaction (9)
- Pathways in cancer (8)
- Cell adhesion molecules (CAMs) (7)
- Focal adhesion (7)
- Hypertrophic cardiomyopathy (HCM) (7)
- Dilated cardiomyopathy (6)
- ECM-receptor interaction (6)
- Hematopoietic cell lineage (6)
- Jak-STAT signaling pathway (6)
- T cell receptor signaling pathway (6)
- Toll-like receptor signaling pathway (6)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (5)
- Regulation of actin cytoskeleton (5)
- Allograft rejection (4)
- Asthma (4)
- Small cell lung cancer (4)
- Apoptosis (3)
- Autoimmune thyroid disease (3)
- Fc epsilon RI signaling pathway (3)
- NOD-like receptor signaling pathway (3)
- Systemic lupus erythematosus (3)
- Adipocytokine signaling pathway (2)
- Alzheimer's disease (2)
- Amyotrophic lateral sclerosis (ALS) (2)
- Chemokine signaling pathway (2)
- Endocytosis (2)
- ErbB signaling pathway (2)
- Fc gamma R-mediated phagocytosis (2)
- Glioma (2)
- Graft-versus-host disease (2)
- Leukocyte transendothelial migration (2)
- MAPK signaling pathway (2)
- Natural killer cell mediated cytotoxicity (2)
- Neurotrophin signaling pathway (2)
- Pathogenic Escherichia coli infection (2)
- Prion diseases (2)
- Prostate cancer (2)
- Acute myeloid leukemia (1)
- Antigen processing and presentation (1)
- B cell receptor signaling pathway (1)
- Calcium signaling pathway (1)
- Chronic myeloid leukemia (1)
- Colorectal cancer (1)
- Complement and coagulation cascades (1)
- Cytosolic DNA-sensing pathway (1)
- Endometrial cancer (1)
- Gap junction (1)
- GnRH signaling pathway (1)
- Insulin signaling pathway (1)
- Long-term potentiation (1)
- Melanogenesis (1)
- Melanoma (1)
- Non-small cell lung cancer (1)
- Olfactory transduction (1)
- Oocyte meiosis (1)
- Pancreatic cancer (1)
- Primary immunodeficiency (1)
- Progesterone-mediated oocyte maturation (1)
- RIG-I-like receptor signaling pathway (1)
- Renal cell carcinoma (1)
- TGF-beta signaling pathway (1)
- Tight junction (1)
- Type I diabetes mellitus (1)
- Type II diabetes mellitus (1)
- VEGF signaling pathway (1)
- Viral myocarditis (1)
- Wnt signaling pathway (1)
- mTOR signaling pathway (1)
- p53 signaling pathway (1)